BML Investment Partners, L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 3:25 pm Purchase |
2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,373,404 11.400% |
167,058 (+7.57%) |
Filing |
| 2024-07-22 4:24 pm Purchase |
2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,206,346 10.600% |
1,065,346 (+93.37%) |
Filing |
| 2024-04-29 4:10 pm Purchase |
2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 1,141,000 5.500% |
655,575 (+135.05%) |
Filing |
| 2024-02-07 11:36 am Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 485,425 2.300% |
-244,593 (-33.51%) |
Filing |
| 2023-02-08 4:44 pm Purchase |
2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 730,018 7.300% |
212,468 (+41.05%) |
Filing |
| 2022-05-10 12:40 pm Purchase |
2022-05-04 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 517,550 5.200% |
517,550 (New Position) |
Filing |